Pmda - Pharmaceuticals and Medical Devices Agency

Jump to body

Navigation of each product type

Our recommended contents

Navigation of each product type

Our recommended contents

Here begins the text.

Post-marketing Safety Measures

Click here for detail

Scientific Research and Analyses

Provision of Information regarding Post-marketing Safety

Regulatory Information

What's newBack number

　　All

May 20, 2022PMDA Risk Communication: Metronidazole, etc. posted
May 13, 2022Revisions of PRECAUTIONS: Dexamethasone (oral dosage form) (preparations indicated for pituitary suppression tests), etc. posted

Pmda - Pharmaceuticals and Medical Devices Agency

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.